2011 Management Specialization Vaccination 
Medical Xpress
JUNE 16, 2025
Ibogaine shows potential for promoting neuroplasticity and aiding recovery, though it carries cardiac risks that require careful management. The initiative aims to attract additional private investment and facilitate FDA approval. This summary was automatically generated using LLM.
FDA Law Blog
DECEMBER 3, 2023
As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). covered insulin product or vaccine). state pharmaceutical assistance programs). Final Guidance at 27.
Expert insights. Personalized for you.
52 
Let's personalize your content